South Korean President Moon:
Trump ‘Should Win the
South Korean President Moon:
Trump ‘Should Win the Nobel Peace Prize’
< >
South Korea’s executive Blue House confirmed on Monday that President Moon Jae-in said U.S. President Donald Trump “should win the Nobel Peace Prize” for his efforts in Korea.
Moon was holding a meeting of his Cabinet on Monday when the conversation turned to a letter of congratulations written to Moon by Lee Hee-ho, the widow of former South Korean President Kim Dae-jung, who died in 2009.
During his presidency, Kim was awarded the 2000 Nobel Peace Prize to recognize “his work for democracy and human rights in South Korea and in East Asia in general, and for peace and reconciliation with North Korea in particular.” The crowning achievement of his work with North Korea was a summit meeting in the summer of 2000 with Kim Jong-il, father of current dictator Kim Jong-un.
A pessimist might glumly note that the meeting with Kim Jong-il ultimately went nowhere, relations with North Korea degenerated to the brink of war over the following two decades, and Kim Dae-jung’s successor, Moon Jae-in, is now making headlines by holding his own historic summit with the new North Korean tyrant. Lee Hee-ho is evidently not a pessimist because she sent a message to Moon congratulating him for the diplomatic breakthrough with North Korea and recommending him for the same Nobel prize her late husband received 18 years ago.
Referring to this letter at his meeting on Monday, Moon reportedly said, “It’s President Trump who should receive the Nobel Prize. We only need to take peace.”
Some media outlets have translated Moon’s comments from Korean in slightly different ways, implying that he was dismissing the Nobel Peace Prize as an unimportant concern.
The translation given above was confirmed by NPR, which proceeded to qualify what sounded like a heartfelt recommendation from Moon by speculating that he simply wanted to flatter Trump to keep him on board with a diplomatic process that gives Seoul at least equal weight as Washington. NPR even implied that Moon noticed the crowd at President Trump’s rally in Michigan on Saturday chanting, “Nobel! Nobel! Nobel!” and deduced that recommending Trump for the Nobel would be a good way to keep him on board.
That reading does not square very well with Moon’s conduct in the presidency or the esteem held for the late President Kim Dae-jung and his wife. The New York Times took Moon’s endorsement of Trump for the Nobel as sincere, noting that other prominent voices in South Korea also believe Trump deserves the award – a remarkable sea change of opinion in Seoul from just a few months ago when there were grave doubts in some quarters about Trump’s approach to the North Korean nuclear missile crisis.
Without citing any factual justification, the New York Times suggests the Moon administration’s appreciation for Trump’s leadership is mixed with an appetite for “stoking the ego of the impulsive American leader so that he would continue to support South Korea’s efforts to resolve the North Korean crisis through dialogue.”
The piece also appears to warn the Nobel committee that Trump “has faced one ethical scandal after another at home,” without citing examples or relevance to the Korean crisis.
For his part, President Trump continued his unconventional approach to diplomacy by crowdsourcing the venue for his upcoming meeting with Kim Jong-un on Twitter:
Donald J. Trump
✔
@realDonaldTrump
Numerous countries are being considered for the MEETING, but would Peace House/Freedom House, on the Border of North & South Korea, be a more Representative, Important and Lasting site than a third party country? Just asking!
8:19 AM - Apr 30, 2018
64.6K
32.2K people are talking about this
Twitter Ads info and privacy
Many American reporters reflexively responded to Moon’s endorsement of Trump for the Nobel by assuming he could not possibly be serious, but commentators around the world are beginning to wonder how the committee could bypass Trump if the North Korean peace initiative pans out.
A fallback wishcasting position for liberal journalists is the hope that a joint Nobel Peace Prize might somehow be awarded to Trump, Moon, and Kim, but there is little precedent for giving the Nobel to someone with as bloody a record as Kim. Granting the award to Trump and Moon but leaving Kim out would be awkward, especially with Moon on the record saying Trump deserves it. However, similar events have occurred as recently as 2016, when Colombian President Juan Manuel Santos – but not the Revolutionary Armed Forces of Colombia (FARC) – won the peace prize for brokering a deal with the terrorist organization.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...
Continue Reading
Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...
Continue Reading
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...
Continue Reading
Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...
Continue Reading
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...
Continue Reading
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...
Continue Reading
Top 5 Most Recently Viewed Articles
Venezuela's Dramatic Political Changes and Market Reactions Recent events in Venezuela have created quite a stir. With the U.S. capturing Nicolás Maduro, the country's president, and extraditing him for trial, one might expect a major upheaval in financial and commodity markets. Surprisingly, the markets seem largely unaffected by this significant geopolitical shift....
Continue Reading
The FDA's Real-Time Game Changer Just up and submitting their convincing response to the FDA, Paradigm Health's grabbing headlines with a trailblazing initiative right out of Columbus, Ohio. The FDA's Real-Time Clinical Trials (RTCT) proof-of-concept has been a field where Paradigm wields its AI-driven wand, proposing a plan that promises to streamline clinical trial...
Continue Reading
DSV A/S Launches Major Share Buyback Program Company Announcement No. 1130 In a strategic effort to boost shareholder value, DSV A/S has launched a share buyback program. This initiative officially began on July 24, 2024, and is expected to wrap up on October 22, 2024. The company plans to repurchase its own shares totaling up to DKK 1,500 million, which corresponds to a...
Continue Reading
Exploring the Global Fondant Market Trends The fondant market is rapidly evolving, driven by a surge in consumer preferences for aesthetically pleasing dessert options. Recent research identifies that the fondant market size, valued at approximately USD 520.45 Million, is anticipated to reach around USD 898.79 Million by 2034, reflecting a robust compound annual growth...
Continue Reading
Innocan Pharma's Exciting Private Placement Initiative Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) has announced a significant financial move by planning a non-brokered private placement. This initiative aims to issue up to 3,500,000 units, priced at C$0.20 each, bringing in gross proceeds of up to C$700,000. This offering is designed to expedite the...
Continue Reading